Hepion Pharmaceuticals, Inc. Shares of Common Stock (par value $ 0.0001 per share) Controlled Equity OfferingSM Sales AgreementSales Agreement • July 21st, 2023 • Hepion Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Hepion Pharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:
